Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Transcept Pharmaceuticals Announces Expected FDA Extension Of Regulatory Review Period For Intermezzo(R)
Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced that the U.S. Food and Drug Administration (FDA) has informed the company that it should expect to receive formal notice of a three month extension of the review period for the new drug application (NDA) for Intermezzo(R) (zolpidem tartrate sublingual tablet). The Intermezzo(R) NDA had been assigned a Prescription Drug User Fee Act (PDUFA) date of July 30, 2009. Under this revised timeline, Transcept now anticipates action from the FDA on the NDA on or before October 31, 2009.
generic viagra online
New Book About Women's Health Looks At The Good And Evil Of Hormones
The evidence is in. Estrogen does not halt aging or protect women from heart disease and dementia, nor is it the safest or best treatment for the hot flashes, night sweats and the insomnia that are associated with menopause and perimenopause. Quite simply - estrogen is not a good and magical hormone - as Susan Baxter, PhD., and Dr. Jerilynn C. Prior, painstakingly prove in their book, The Estrogen Errors; Why Progesterone is Better for Women"s Health.
News of the day
Pediatric Carbon Monoxide Poisoning Linked To Video Games After Hurricane Ike
Hours after Hurricane Ike roared ashore in Texas, more than two million homes were without power, which left some scrambling to preserve food and others looking for ways to entertain children, a move that proved to be, in some instances, poisonous. Researchers at The University of Texas Health Science Center at Houston found that 75 percent of children treated for carbon monoxide poisoning caused by gasoline-powered electrical generators were playing video games
Oncology

Conference: Discovery Partnerships: Academia & Industrial Interactions

Opal Events is proud to present our next exciting conference Drug Discovery Partnerships: Academia & Industrial Interactions , to be held at the Hyatt Regency in Boston on October 28-30, 2009. Early stage drug discovery is a key bottleneck in the pipeline to find novel drugs. With key products suffering patent expiration in coming years, the need for new approaches to accelerate development of new chemical entities to treat severely unmet medical needs is more urgent than ever. This event brings together pharmaceutical companies, universities, small biotechnology enterprises, government agencies, for-profit and not-for profit research institutions to exchange ideas, make connections and discuss opportunities to create an environment that will foster pharmaceutical innovation. Overcome Your Most Critical Challenges in forming Academia-Industrial Partnerships: - Understand Specific Requirements Regarding Investigational New Drug (IND) Application and Approval Process - Maximize the Value and Minimize the Risk by Partnering with the Right Entity - Hear Insider"s Guide to Securing Grant Money for Your Drug Discovery Project - Examine Recent United States Decisions and their Impact on Pharmaceutical and Academia Patenting - Improve Speed to Market with Seamless Alignment on Science and Technology Who Will Attend? Pharmaceuticals, Biotechs, Academia, Foundations, Technology Companies and CRO"s - Managers/ Directors/ VP"s/ Faculty Advisors of: - External Research Collaboration - Scientific Affairs - Business Development - Partnership/ Alliance Management - Office of Technology Transfer - Academic Screening Facilities - School of Medicine/ Life Sciences/ Pharmacy - Grants Manager - Program Officer - Research & Development Sponsorship and Exhibiting Opportunities If you are interested in sponsorship, exhibiting or speaking opportunities, please contact Kay Ye at kye@opalevents.org or 212 532-9898, extension 263. Register Registration is already open on our website here. Sign up today! Opal Events


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009